These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18846914)

  • 1. Minimizing risks to drugs.
    Kshirsagar NA; Gogtay NJ
    J Assoc Physicians India; 2008 Jul; 56():556-7. PubMed ID: 18846914
    [No Abstract]   [Full Text] [Related]  

  • 2. European Medicines Agency--more transparency needed.
    Lancet; 2010 May; 375(9728):1753. PubMed ID: 20494710
    [No Abstract]   [Full Text] [Related]  

  • 3. Asymmetric assessments in valuing pharmaceutical risks.
    Viscusi WK; Magat WA; Scharff R
    Med Care; 1996 Dec; 34(12 Suppl):DS34-47. PubMed ID: 8969313
    [No Abstract]   [Full Text] [Related]  

  • 4. Here I stand ... two key figures in the animal experiments debate draw different lessons from public attitudes.
    Blakemore C; Langley G
    New Sci; 1999 May; 162(2187):60-1. PubMed ID: 11657972
    [No Abstract]   [Full Text] [Related]  

  • 5. The FDA and the IOM report.
    Galson SK
    N Engl J Med; 2007 Dec; 357(24):2520-1; author reply 2521-2. PubMed ID: 18077820
    [No Abstract]   [Full Text] [Related]  

  • 6. Safe drugs and the cost of good intentions.
    Eichler HG; Abadie E; Raine JM; Salmonson T
    N Engl J Med; 2009 Apr; 360(14):1378-80. PubMed ID: 19339718
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk management and intrusions on medical practice: striking a balance.
    Enzi MB; Kennedy EM
    Health Aff (Millwood); 2007; 26(3):678-80. PubMed ID: 17485743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk management: issues for outcomes research.
    Woodcock J
    Value Health; 2003; 6(4):420-4. PubMed ID: 12859582
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
    Schott M
    Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug trials in children: problems and the way forward.
    Conroy S; McIntyre J; Choonara I; Stephenson T
    Br J Clin Pharmacol; 2000 Feb; 49(2):93-7. PubMed ID: 10671901
    [No Abstract]   [Full Text] [Related]  

  • 11. European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287.
    Flavell DJ; Flavell SU; Sullivan R
    Lancet; 2003 Oct; 362(9393):1415. PubMed ID: 14585646
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical and Medical Devices: FDA Oversight.
    White RS;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-97. PubMed ID: 27116797
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulating nanomedicine.
    Nat Mater; 2007 Apr; 6(4):249. PubMed ID: 17401411
    [No Abstract]   [Full Text] [Related]  

  • 14. An analysis of legal warnings after drug approval in Thailand.
    Sriphiromya P; Theeraroungchaisri A
    Regul Toxicol Pharmacol; 2015 Feb; 71(1):108-13. PubMed ID: 25445000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug lag for cardiovascular drug approvals in India compared with the US and EU approvals.
    Kataria BC; Mehta DS; Chhaiya SB
    Indian Heart J; 2013; 65(1):24-9. PubMed ID: 23438609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: FDA oversight.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-123. PubMed ID: 24482893
    [No Abstract]   [Full Text] [Related]  

  • 17. Sidelining safety--the FDA's inadequate response to the IOM.
    Smith SW
    N Engl J Med; 2007 Sep; 357(10):960-3. PubMed ID: 17804840
    [No Abstract]   [Full Text] [Related]  

  • 18. More Halcion headaches.
    Cowley G
    Newsweek; 1994 Mar; 123(10):50-2. PubMed ID: 11652702
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective.
    Bakke OM; Manocchia M; de Abajo F; Kaitin KI; Lasagna L
    Clin Pharmacol Ther; 1995 Jul; 58(1):108-17. PubMed ID: 7628177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of risk-management plans.
    Meltzer D
    Health Aff (Millwood); 2007; 26(3):681-3. PubMed ID: 17485744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.